Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn’s acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK). The unanimous vote in support of the transactions follows Akorn’s ...
read more
Almac’s diagnostics business unit today announced that it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing them to receive patient samples for clinical testing from New York.
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer ("CMO") of mammalian and microbial biologics, is pleased to participate in the Buzz of BIO for the 2014 BIO International Convention. Hosted by the Biotechnology Industry ...
read more
Penn Pharma, a leading global provider of integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry, today announced the completion of potent compound safety training and certification for ...
read more
ResearchDx, LLC of Irvine, California announced today that it has received a 2013
Strategic Partner Award from WuXi AppTec, Ltd. The award was given in recognition
of the outstanding consulting and personnel services provided to the WuXi AppTec
...
read more
Wednesday, April 16, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has led a consortium, also comprising Charnwood Technical Consulting, CatScI and Biocatalysts, which has successfully won a Technology Strategy Board grant...
read more
Wednesday, April 16, 2014
Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and ...
read more
Wednesday, April 02, 2014
Vetter has announced significant progress in its solution for state-of-the-art product packaging, designed to support the prevention of product counterfeiting. This innovative development is in response to expanded requirements by official regulatory...
read more
Wednesday, April 02, 2014
OsoBio has appointed Catherine R. Buck director of manufacturing. In her capacity, Buck is responsible for ensuring that OsoBio’s operations comply with current Good Manufacturing Practices (cGMP) as they apply to the manufacturing of injectable ...
read more
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has today announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma’s engineered ...
read more
JLL Partners (JLL), the middle-market private equity firm, and Royal DSM (Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announced the successful closing of the transaction announced in November 2013 combining DSM ...
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced that its High Capacity Manufacturing Facility has been successfully validated for commercial production. $45m (USD) has been invested at...
read more
Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. („Finesse“), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient ...
read more
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics ...
read more
Cobra Biologics, a leading contract manufacturer of clinical and commercial scale biologics and pharmaceuticals, and targeted cancer therapy company BioCancell have announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical ...
read more